Research Guidelines for Evaluating the Safety and Efficacy of Herbal Medicines
(1993; 94 pages)
Índice de contenido
Ver el documentoFOREWORD
Abrir esta carpeta y ver su contenido1. INTRODUCTION
Abrir esta carpeta y ver su contenido2. GENERAL CONSIDERATIONS IN HERBAL MEDICINE RESEARCH
Cerrar esta carpeta3. RESEARCH STUDIES
Ver el documentoLITERATURE BACKGROUND
Ver el documentoPROTOCOL PREPARATION
Ver el documentoQUALITY SPECIFICATIONS OF PLANT MATERIALS AND PREPARATION
Abrir esta carpeta y ver su contenidoNON-CLINICAL STUDIES
Cerrar esta carpetaCLINICAL TRIALS USING HERBAL MEDICINES
Ver el documentoCLINICAL TRIAL PROTOCOL DEVELOPMENT
Ver el documentoPHASES OF A CLINICAL TRIAL
Ver el documentoETHICS REVIEW BOARD
Ver el documentoRESPONSIBILITIES OF INVESTIGATORS
Ver el documentoRESPONSIBILITIES OF THE SPONSOR
Ver el documentoDATA MANAGEMENT
Ver el documentoSTATISTICAL ANALYSIS
Ver el documentoREPORTING
Ver el documentoEVALUATION OF HERBAL MEDICINE RESEARCH
Abrir esta carpeta y ver su contenidoTECHNOLOGY TRANSFER AND EDUCATION
Abrir esta carpeta y ver su contenido4. USING THE GUIDELINES
Abrir esta carpeta y ver su contenidoANNEXES
Ver el documentoNOTES
Ver el documentoBIBLIOGRAPHY
Ver el documentoSELECTED WHO PUBLICATIONS OF RELATED INTEREST
 

REPORTING

The Chief Investigator will be responsible for preparing a final report of the trial which should be provided to the sponsor, the ethics review board, and any other authorities determined by local legislation. The results of the trials conducted on a herbal medicine should be published in a timely fashion and must include all significant positive and negative results. Even studies which fail to demonstrate efficacy should be published, as selective publication, showing only results that are favourable, will only lead to a form of misconception known as publication bias.

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013